Anxiety and Related Sleep Disorders - GCC

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$135.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.11%, resulting in a market volume of US$136.30m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$36.23 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in GCC is experiencing steady growth due to increasing customer preferences for natural remedies and a rising awareness about mental health.

Customer preferences: Customers in the GCC region are increasingly opting for natural remedies to manage anxiety and sleep disorders. This shift in preference can be attributed to the growing awareness about the potential side effects of pharmaceutical drugs and a desire for holistic approaches to health and wellness. Natural remedies such as herbal supplements, aromatherapy, and relaxation techniques are gaining popularity among consumers in the GCC region.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in the GCC is the rising demand for herbal supplements. Herbal supplements are perceived as a safer alternative to pharmaceutical drugs and are believed to have fewer side effects. Consumers in the GCC region are increasingly turning to herbal supplements such as chamomile, lavender, and valerian root to manage their anxiety and sleep disorders.Another trend in the market is the growing popularity of aromatherapy. Aromatherapy involves the use of essential oils to promote relaxation and improve sleep quality. Essential oils such as lavender, bergamot, and chamomile are commonly used in aromatherapy for their calming and sleep-inducing properties. The demand for essential oils and aromatherapy products is on the rise in the GCC region as consumers seek natural and non-invasive solutions for their anxiety and sleep disorders.

Local special circumstances: The GCC region has a high prevalence of anxiety and sleep disorders due to various factors such as work-related stress, lifestyle changes, and cultural influences. The fast-paced and competitive nature of the business environment in the GCC countries often leads to increased stress levels among individuals, which can contribute to the development of anxiety and sleep disorders. Additionally, cultural factors such as the importance placed on social status and the pressure to meet societal expectations can also contribute to anxiety and sleep disorders in the GCC region.

Underlying macroeconomic factors: The growing awareness about mental health and the increasing focus on holistic wellness are driving the growth of the Anxiety and Related Sleep Disorders market in the GCC. The GCC region has witnessed a rise in mental health awareness campaigns and initiatives, which have helped reduce the stigma associated with anxiety and sleep disorders. This, coupled with a growing middle class and increasing disposable income, has contributed to the increasing demand for products and services related to anxiety and sleep disorders in the GCC region.In conclusion, the Anxiety and Related Sleep Disorders market in the GCC is witnessing steady growth due to customer preferences for natural remedies, increasing awareness about mental health, and underlying macroeconomic factors such as rising disposable income and a growing middle class. The market is characterized by a shift towards natural remedies, with herbal supplements and aromatherapy gaining popularity among consumers. The high prevalence of anxiety and sleep disorders in the GCC region, along with cultural and lifestyle factors, further contribute to the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.